GC Biopharma Corp. (KRX:006280)
South Korea · Delayed Price · Currency is KRW 167,000
+500 (0.30%)
At close: Dec 19, 2025
GC Biopharma Market Cap
GC Biopharma has a market cap or net worth of 1.91 trillion as of December 19, 2025. Its market cap has increased by 24.16% in one year.
Market Cap
1.91T
Enterprise Value
3.05T
Revenue
1.93T
Ranking
n/a
PE Ratio
33.84
Stock Price
167,000.00
Market Cap Chart
Since August 29, 1995, GC Biopharma's market cap has increased from 29.09B to 1.91T, an increase of 6,453.04%. That is a compound annual growth rate of 14.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 1.91T | -6.96% |
| Dec 30, 2024 | 2.05T | 43.03% |
| Dec 28, 2023 | 1.43T | -3.09% |
| Dec 29, 2022 | 1.48T | -40.60% |
| Dec 30, 2021 | 2.49T | -46.31% |
| Dec 30, 2020 | 4.63T | 206.42% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 80.45T |
| Celltrion | 39.93T |
| ALTEOGEN | 22.52T |
| SK Biopharmaceuticals | 10.26T |
| ABL Bio | 10.04T |
| Yuhan | 8.53T |
| LigaChem Biosciences | 6.14T |
| HLB Co., Ltd. | 6.11T |